Evidence map›Paper›PMID 42745760›Full record

ArticleFrontiers in immunology2026

Rafeh Oualha, Yosser Zina Abdelkrim, Mourad Barhoumi, Sonia Ben Hamouda, Imen Bassoumi-Jamoussi, Makram Essafi, Melika Ben Ahmed, Khadija Essafi-Benkhadir, Ikram Guizani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rafeh OualhaLaboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Yosser Zina AbdelkrimLaboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Mourad BarhoumiLaboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Sonia Ben HamoudaLaboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Imen Bassoumi-JamoussiLaboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Makram EssafiLaboratory of Transmission, Control and Immunobiology of Infections, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Melika Ben AhmedLaboratory of Transmission, Control and Immunobiology of Infections, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Khadija Essafi-BenkhadirLaboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Ikram GuizaniLaboratory of Molecular Epidemiology and Experimental Pathology, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Leishmaniases are a group of neglected tropical diseases caused by

Indexed as

Leishmania infantumLeishmaniasis, VisceralNeutrophilsProtozoan ProteinsApoptosisCells, CulturedCytokinesHumansNeutrophil Activationp38 Mitogen-Activated Protein KinasesReactive Oxygen SpeciesCytokinesp38 Mitogen-Activated Protein KinasesProtozoan ProteinsReactive Oxygen Speciescellular effectorsexcreted/secreted Leishmania productsinnate immunityLieIF (Leishmania infantum eukaryotic initiation factor 4A)neutrophils

Identifiers

PMID42745760
PMCPMC13574617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.